EFNA5 and carcinoma: Ephrin-A1 and ephrin-A5 elevated expression in tumorous specimens was linked to decreased survival [77], while ephrin-B1 overexpression, more frequently observed in high-grade carcinomas, was correlated with an increased recurrence rate and decreased OS [83].